Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management

by Laura Ramiro, Alba Simats, Teresa García-Berrocoso, Joan Montaner
Published 2018-08-01

Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections

by Júlia Faura, Alejandro Bustamante, Francesc Miró-Mur, Joan Montaner
Published 2021-06-01

An Inflammatory Polymorphisms Risk Scoring System for the Differentiation of Ischemic Stroke Subtypes

by Elena Muiño, Jurek Krupinski, Caty Carrera, Cristina Gallego-Fabrega, Joan Montaner, Israel Fernández-Cadenas
Published 2015-01-01

Selection bias in clinical stroke trials depending on ability to consent

by Benjamin Hotter, Lena Ulm, Sarah Hoffmann, Mira Katan, Joan Montaner, Alejandro Bustamante, Andreas Meisel
Published 2017-12-01

Nutraceuticals in the Prevention of Neonatal Hypoxia–Ischemia: A Comprehensive Review of their Neuroprotective Properties, Mechanisms of Action and Future Directions

by Marta Reyes-Corral, Noelia Sola-Idígora, Rocío de la Puerta, Joan Montaner, Patricia Ybot-González
Published 2021-03-01

Antibiotic Class and Outcome in Post-stroke Infections: An Individual Participant Data Pooled Analysis of VISTA-Acute

by Craig J. Smith, Craig J. Smith, Calvin Heal, Andy Vail, Adam R. Jeans, Willeke F. Westendorp, Paul J. Nederkoorn, Diederik van de Beek, Lalit Kalra, Joan Montaner, Joan Montaner, Mark Woodhead, Andreas Meisel
Published 2019-05-01

Angiogenin in the Neurogenic Subventricular Zone After Stroke

by Marina Gabriel-Salazar, Ting Lei, Alba Grayston, Carme Costa, Esperanza Medina-Gutiérrez, Manuel Comabella, Joan Montaner, Anna Rosell
Published 2021-06-01

Allogeneic adipose tissue-derived mesenchymal stem cells in ischaemic stroke (AMASCIS-02): a phase IIb, multicentre, double-blind, placebo-controlled clinical trial protocol

by Joan Montaner, Francisco Moniche, Alberto M Borobia, Blanca Fuentes, Exuperio Diez-Tejedor, Elena de Celis-Ruiz, Maria Gutiérrez-Fernández
Published 2021-08-01

Circulating cell-free DNA is a predictor of short-term neurological outcome in stroke patients treated with intravenous thrombolysis

by Alejandro Bustamante, Fernando Mancha, Hada C Macher, Teresa García-Berrocoso, Dolors Giralt, Marc Ribó, Juan M Guerrero, Joan Montaner
Published 2016-09-01

Matrix metalloproteinase-13 participates in neuroprotection and neurorepair after cerebral ischemia in mice

by Feifei Ma, Pablo Martínez-San Segundo, Verónica Barceló, Anna Morancho, Marina Gabriel-Salazar, Dolors Giralt, Joan Montaner, Anna Rosell
Published 2016-07-01

Rat middle cerebral artery occlusion is not a suitable model for the study of stroke-induced spontaneous infections.

by Mireia Campos-Martorell, Ma Ángeles Montero, Mar Hernández-Guillamón, Anna Rosell, Javier Gomis, David Salat, Lidia García-Bonilla, Joan Montaner
Published 2014-01-01

Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL

by Elena Muiño, Cristina Gallego-Fabrega, Natalia Cullell, Caty Carrera, Nuria Torres, Jurek Krupinski, Jaume Roquer, Joan Montaner, Israel Fernández-Cadenas
Published 2017-09-01

New candidate blood biomarkers potentially associated with white matter hyperintensities progression

by Joan Jiménez-Balado, Jesús Pizarro, Iolanda Riba-Llena, Anna Penalba, Júlia Faura, Elena Palà, Joan Montaner, Mar Hernández-Guillamon, Pilar Delgado
Published 2021-07-01

Ubiquitin Fusion Degradation Protein 1 as a Blood Marker for The Early Diagnosis of Ischemic Stroke

by Laure Allard, Natacha Turck, Pierre R. Burkhard, Nadia Walter, Anna Rosell, Marianne Gex-Fabry, Denis F. Hochstrasser, Joan Montaner, Jean-Charles Sanchez
Published 2007-01-01

Automated quantification of cerebral edema following hemispheric infarction: Application of a machine-learning algorithm to evaluate CSF shifts on serial head CTs

by Yasheng Chen, Rajat Dhar, Laura Heitsch, Andria Ford, Israel Fernandez-Cadenas, Caty Carrera, Joan Montaner, Weili Lin, Dinggang Shen, Hongyu An, Jin-Moo Lee
Published 2016-01-01

Importance of Angiogenin and Endothelial Progenitor Cells After Rehabilitation Both in Ischemic Stroke Patients and in a Mouse Model of Cerebral Ischemia

by Marina Gabriel-Salazar, Anna Morancho, Susana Rodriguez, Xavi Buxó, Nicolás García-Rodríguez, Guillem Colell, Albert Fernandez, Dolors Giralt, Alejandro Bustamante, Joan Montaner, Anna Rosell
Published 2018-06-01

Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis

by Sofía Fernández-de-Retana, Mary Cano-Sarabia, Paula Marazuela, Jose Luis Sánchez-Quesada, Annabel Garcia-Leon, Alex Montañola, Joan Montaner, Daniel Maspoch, Mar Hernández-Guillamon
Published 2017-11-01

Rehabilitation Profiles of Older Adult Stroke Survivors Admitted to Intermediate Care Units: A Multi-Centre Study.

by Laura M Pérez, Marco Inzitari, Terence J Quinn, Joan Montaner, Ricard Gavaldà, Esther Duarte, Laura Coll-Planas, Mercè Cerdà, Sebastià Santaeugenia, Conxita Closa, Miquel Gallofré
Published 2016-01-01

Blood glutathione S-transferase-π as a time indicator of stroke onset.

by Natacha Turck, Xavier Robin, Nadia Walter, Catherine Fouda, Alexandre Hainard, Roman Sztajzel, Ghislaine Wagner, Denis F Hochstrasser, Joan Montaner, Pierre R Burkhard, Jean-Charles Sanchez
Published 2012-01-01

Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice

by Sofía Fernández de Retana, Paula Marazuela, Montse Solé, Guillem Colell, Anna Bonaterra, Jose Luis Sánchez-Quesada, Joan Montaner, Daniel Maspoch, Mary Cano-Sarabia, Mar Hernández-Guillamon
Published 2019-05-01